Edith Perez, M.D., was appointed Chief Medical Officer of Bolt Biotherapeutics in April 2020 to lead clinical development of the company's cancer.
Edith Perez, M.D., was appointed Chief Medical Officer of Bolt Biotherapeutics in April 2020 to lead clinical development of the company's cancer immunotherapies. She is a physician-scientist with prior affiliations including Mayo Clinic and Mayo Medical School. As of 2025, her mailing address is in Redwood City, California.
Full founder directory · Investor directory · Company funding database · Fundraising library